India
Pulmonology · 4 min read

Asbestos intoxication

Learn about Asbestos intoxication, its reported features, relevant specialists, and questions to discuss at a medical consultation.

Also known as: Asbestosis

Compiled from public sources
Text selected and arranged from Orphanet. It describes the condition as those sources do; it has not been rewritten for India.
01 Oct 2026
Not medically reviewed
No registered doctor has reviewed this page. Use it to decide who to see and what to ask — not to diagnose or treat.
—
This is not medical advice. If symptoms are severe, sudden or getting worse, call 112 (or 108 for an ambulance) or go to the nearest emergency department.

The sources compiled here do not cover: diagnosis, treatment, prevention. Ask the treating doctor about these.

What it is

From: Orphanet

A rare pneumoconiosis caused by exposure to asbestos particles. Symptoms may appear many years after exposure and include progressive dyspnea on exertion, dry cough, chest pain, tightness, inspiratory crackles, clubbing of the fingers. Later complications include mesothelioma and lung cancers.

Reported clinical features and what the terms mean

The following findings are associated with this condition in Orphanet. They are not a checklist for diagnosing yourself, and they do not all occur in every affected person. Some are examination, imaging or laboratory findings that cannot be recognised at home.

The frequency labels describe how often a finding was reported among people with the condition in the source. They do not give the chance that a person with that symptom has the condition. Definitions below reproduce HPO terminology; they explain the term, not the likely severity in an individual.

Abnormal pulmonary interstitial morphology · Frequent (79-30%)
Abnormality of the lung parenchyma extending to the pulmonary interstitium and leading to diffuse pulmonary fibrosis.
Abnormality of the respiratory system · Frequent (79-30%)
An abnormality of the respiratory system, which include the airways, lungs, and the respiratory muscles.
Decreased DLCO · Frequent (79-30%)
Reduced ability of the lungs to transfer gas from inspired air to the bloodstream as measured by the diffusing capacity of the lungs for carbon monoxide (DLCO) test.
Dyspnea · Frequent (79-30%)
Difficult or labored breathing. Dyspnea is a subjective feeling only the patient can rate, e.g., on a Borg scale.
Exercise intolerance · Frequent (79-30%)
A functional motor deficit where individuals whose responses to the challenges of exercise fail to achieve levels considered normal for their age and gender.
Exertional dyspnea · Frequent (79-30%)
Perceived difficulty to breathe that occurs with exercise or exertion and improves with rest.
Late inspiratory crackles · Frequent (79-30%)
Crackles that appear any time after the beginning of inspiration and last till the end of inspiration.
Nonproductive cough · Frequent (79-30%)
A cough that does not produce phlegm or mucus.
Oxygen desaturation on exertion · Frequent (79-30%)
Oxygen saturation less than 95% on exertion or arterial partial pressure of oxygen falling by more than 1kPa.
Pleural thickening · Frequent (79-30%)
An increase in the thickness of the pleura, generally related to scarring of the pleural tissue.
Reduced forced vital capacity · Frequent (79-30%)
An abnormal reduction in the amount of air a person can expel following maximal inspiration.
Reduced vital capacity · Frequent (79-30%)
An abnormal reduction on the vital capacity, which is defined as the total lung capacity (volume of air in the lungs at maximal inflation) less the residual volume (i.e., volume of air in the lungs following maximal exhalation) of the lung.
Restrictive ventilatory defect · Frequent (79-30%)
A functional defect characterized by reduced total lung capacity (TLC) not associated with abnormalities of expiratory airflow or airway resistance. Spirometrically, a restrictive defect is defined as FEV1 (forced expiratory volume in 1 second) and FVC (forced vital capacity) less than 80 per cent. Restrictive lung disease may be caused by alterations in lung parenchyma or because of a disease of the pleura, chest wall, or neuromuscular apparatus.
Subpleural honeycombing · Frequent (79-30%)
So-called honeycombs (variably sized cysts in a background of densely scarred tissue) located in the subpleural space.

Other findings in the same source

From: Orphanet

Additional reported features include Diffuse reticular or finely nodular infiltrations (Frequent (79-30%)); Abnormal sputum (Occasional (29-5%)); Chest pain (Occasional (29-5%)); Chest tightness (Occasional (29-5%)); Clubbing of fingers (Occasional (29-5%)); Cor pulmonale (Occasional (29-5%)); Cyanosis (Occasional (29-5%)); Ground-glass opacification on pulmonary HRCT (Occasional (29-5%)); Hepatojugular reflux (Occasional (29-5%)); Hypoxemia (Occasional (29-5%)). This is a selected summary, not a complete description of the condition.

When it may begin

From: Orphanet

All ages

Frequency and the population described

From: Orphanet

Point prevalence: Unknown; Worldwide; Class only.

Which doctor should you see?

The suggested department for discussing Asbestos intoxication is Pulmonology, with a pulmonologist / chest physician as the relevant type of clinician. General physician / Family Medicine; paediatrician for children. Referral depends on symptoms.

This is an editorial referral starting point. The appropriate clinic depends on the person’s age, symptoms, previous diagnosis and local services. The first clinician can decide whether another specialty or a team is needed; a department label does not confirm the diagnosis.

How to prepare for an assessment

Bring a short timeline of the main symptoms: when they first appeared, whether they are constant or episodic, what seems to change them, and how they affect daily activities. Include previous reports, discharge summaries, current medicines and supplements, allergies, and any relevant family history. A dated record is more useful than trying to match every feature in an online article.

Ask the clinician what is already established and what remains uncertain. If a test is suggested, ask what question it answers, what its limitations are and how the result would change the next step. The information here is not an instruction to arrange every possible test. In children, bring growth, developmental and school information if it is relevant to the concern.

  • What is the likely explanation for the breathing symptoms?
  • Would a breathing test or another investigation change management?
  • If symptoms worsen, what written action plan should be followed?

Treatment discussions and follow-up

The material gathered for this draft does not provide a complete condition-specific treatment pathway for Asbestos intoxication. That gap does not mean that treatment is unavailable. A clinician needs to establish the diagnosis and review current guidance before recommending medicines, procedures, rehabilitation or other support.

Before leaving the appointment, clarify the next review date, who will communicate results, and whom to contact if the situation changes. Discuss difficulties with sleep, work, school, mobility, eating or emotional wellbeing when these are relevant. Practical support may require coordination between the treating clinician and other services.

The collected references do not establish a complete prevention or long-term outlook section for this entry. Missing information should not be interpreted as proof that prevention is impossible or that a particular outcome is inevitable. Ask what is known for the exact subtype, stage and personal circumstances, and which uncertainties remain.

When to seek emergency help

Severe breathing difficulty, collapse, new stroke-like symptoms, a seizure that is prolonged or repeated without recovery, uncontrolled major bleeding, or an immediate risk of self-harm require emergency help. In India, call 112 or reach the nearest emergency department. This is a general, non-exhaustive warning list; it is not a condition-specific triage tool.

Find a doctor for Asbestos intoxication

This condition is usually assessed by a pulmonologist. Every profile shows the doctor’s registration and what has been checked.

All pulmonology conditions →

Sources

Source: MedlinePlus, National Library of Medicine. Orphadata Science: Free access data from Orphanet. © INSERM 1999; July 2026 data, CC BY 4.0. This product uses the Human Phenotype Ontology (hp/releases/2026-09-01). Only sources listed for this article apply. Source material has been selected and arranged; HPO definitions are reproduced without alteration. No source organisation endorses this compilation. Köhler S et al. The Human Phenotype Ontology project: linking molecular biology and disease through phenotype data. Nucleic Acids Research 2014;42(D1):D966–D974. doi:10.1093/nar/gkt1026.

General information, not advice about your situation. Errors can be reported through the corrections process. Reference TDI-C-0223.